Press Releases
Advancing Japan’s biopharmaceutical landscape: the evolving role of global CDMOs
In the face of growing demand for next-generation therapeutics, Samsung Biologics has been expanding its capabilities and global footprint to provide tailored services to clients in closer proximity.
In this PHARMTECH JAPAN article, Jahoon Kang, Vice President of CDO Sales, shares insights on key development challenges and how Samsung Biologics has the expertise to support Japanese biopharmaceutical companies.
Read the full interview (Japanese) here
In the face of growing demand for next-generation therapeutics, Samsung Biologics has been expanding its capabilities and global footprint to provide tailored services to clients in closer proximity.
In this PHARMTECH JAPAN article, Jahoon Kang, Vice President of CDO Sales, shares insights on key development challenges and how Samsung Biologics has the expertise to support Japanese biopharmaceutical companies.